101 related articles for article (PubMed ID: 6802493)
1. Epidermal tumor promotion by regeneration.
Argyris TS
Carcinog Compr Surv; 1982; 7():43-8. PubMed ID: 6802493
[No Abstract] [Full Text] [Related]
2. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J
Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598
[TBL] [Abstract][Full Text] [Related]
3. On the relationship between epidermal hyperproliferation and skin tumor promotion.
Marks F; Berry DL; Bertsch S; Fürstenberger G; Richter H
Carcinog Compr Surv; 1982; 7():331-46. PubMed ID: 6802490
[No Abstract] [Full Text] [Related]
4. Mouse skin cells resistant to terminal differentiation associated with initiation of carcinogenesis.
Yuspa SH; Morgan DL
Nature; 1981 Sep; 293(5827):72-4. PubMed ID: 6791032
[No Abstract] [Full Text] [Related]
5. Protein kinase Cdelta-mediated signal to ornithine decarboxylase induction is independent of skin tumor suppression.
Wheeler DL; Reddig PJ; Dreckschmidt NE; Leitges M; Verma AK
Oncogene; 2002 May; 21(22):3620-30. PubMed ID: 12032864
[TBL] [Abstract][Full Text] [Related]
6. Evidence that the epidermal targets of carcinogen action are found in the interfollicular epidermis of infundibulum as well as in the hair follicles.
Morris RJ; Tryson KA; Wu KQ
Cancer Res; 2000 Jan; 60(2):226-9. PubMed ID: 10667563
[TBL] [Abstract][Full Text] [Related]
7. A novel polypeptide p10 expressed in tumor-promoter-treated murine epidermis and in untreated neonatal murine epidermis.
Schlatterer K; Schlatterer B; Krauter G; Hecker E; Chandra P
Anticancer Res; 2000; 20(1A):289-92. PubMed ID: 10769669
[TBL] [Abstract][Full Text] [Related]
8. Evidence that cutaneous carcinogen-initiated epithelial cells from mice are quiescent rather than actively cycling.
Morris RJ; Coulter K; Tryson K; Steinberg SR
Cancer Res; 1997 Aug; 57(16):3436-43. PubMed ID: 9270010
[TBL] [Abstract][Full Text] [Related]
9. Stages of tumour promotion in skin.
Marks F; Fürstenberger G
IARC Sci Publ; 1984; (56):13-22. PubMed ID: 6443102
[No Abstract] [Full Text] [Related]
10. Overexpression of bone morphogenetic protein-6 (BMP-6) in murine epidermis suppresses skin tumor formation by induction of apoptosis and downregulation of fos/jun family members.
Wach S; Schirmacher P; Protschka M; Blessing M
Oncogene; 2001 Nov; 20(53):7761-9. PubMed ID: 11753654
[TBL] [Abstract][Full Text] [Related]
11. Transgenic mice overexpressing protein kinase C epsilon in their epidermis exhibit reduced papilloma burden but enhanced carcinoma formation after tumor promotion.
Reddig PJ; Dreckschmidt NE; Zou J; Bourguignon SE; Oberley TD; Verma AK
Cancer Res; 2000 Feb; 60(3):595-602. PubMed ID: 10676642
[TBL] [Abstract][Full Text] [Related]
12. Genetic deletion of p21WAF1 enhances papilloma formation but not malignant conversion in experimental mouse skin carcinogenesis.
Weinberg WC; Fernandez-Salas E; Morgan DL; Shalizi A; Mirosh E; Stanulis E; Deng C; Hennings H; Yuspa SH
Cancer Res; 1999 May; 59(9):2050-4. PubMed ID: 10232585
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol sulfate, a second messenger for the eta isoform of protein kinase C, inhibits promotional phase in mouse skin carcinogenesis.
Chida K; Murakami A; Tagawa T; Ikuta T; Kuroki T
Cancer Res; 1995 Nov; 55(21):4865-9. PubMed ID: 7585521
[TBL] [Abstract][Full Text] [Related]
14. Simple phorbol esters as inhibitors of tumor promotion by TPA in mouse skin.
Schmidt R; Hecker E
Carcinog Compr Surv; 1982; 7():57-63. PubMed ID: 7066929
[No Abstract] [Full Text] [Related]
15. Human keratin-1.bcl-2 transgenic mice aberrantly express keratin 6, exhibit reduced sensitivity to keratinocyte cell death induction, and are susceptible to skin tumor formation.
Rodríguez-Villanueva J; Greenhalgh D; Wang XJ; Bundman D; Cho S; Delehedde M; Roop D; McDonnell TJ
Oncogene; 1998 Feb; 16(7):853-63. PubMed ID: 9484776
[TBL] [Abstract][Full Text] [Related]
16. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
Greenhalgh DA; Wang XJ; Donehower LA; Roop DR
Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthase and skin tumor promotion.
Ahmad N; Srivastava RC; Agarwal R; Mukhtar H
Biochem Biophys Res Commun; 1997 Mar; 232(2):328-31. PubMed ID: 9125174
[TBL] [Abstract][Full Text] [Related]
18. Patterns of epidermal cell proliferation.
Mackenzie IC; Bickenbach JR
Carcinog Compr Surv; 1982; 7():311-7. PubMed ID: 6175413
[No Abstract] [Full Text] [Related]
19. Overexpression of insulin-like growth factor-1 induces hyperplasia, dermal abnormalities, and spontaneous tumor formation in transgenic mice.
Bol DK; Kiguchi K; Gimenez-Conti I; Rupp T; DiGiovanni J
Oncogene; 1997 Apr; 14(14):1725-34. PubMed ID: 9135074
[TBL] [Abstract][Full Text] [Related]
20. Disruption of protein kinase Ceta results in impairment of wound healing and enhancement of tumor formation in mouse skin carcinogenesis.
Chida K; Hara T; Hirai T; Konishi C; Nakamura K; Nakao K; Aiba A; Katsuki M; Kuroki T
Cancer Res; 2003 May; 63(10):2404-8. PubMed ID: 12750259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
